AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 446,500 shares, a growth of 38.4% from the February 13th total of 322,700 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is currently 99.2 days.

AstraZeneca Stock Performance

Shares of AZNCF opened at $154.98 on Tuesday. AstraZeneca has a 12-month low of $120.64 and a 12-month high of $175.00. The stock’s 50-day moving average price is $143.70 and its 200 day moving average price is $144.05.

AstraZeneca Increases Dividend

The company also recently declared a dividend, which will be paid on Monday, March 24th. Investors of record on Friday, February 21st will be paid a dividend of $2.10 per share. This is a positive change from AstraZeneca’s previous dividend of $1.00. The ex-dividend date is Wednesday, February 19th. AstraZeneca’s payout ratio is currently 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.